San Jose, CA, United States of America

Brad Holinski

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Brad Holinski

Introduction

Brad Holinski is a notable inventor based in San Jose, CA. He has made significant contributions to the field of neuromodulation, particularly in the treatment of metabolic disorders. With a total of 2 patents, his work focuses on devices that inhibit neural activity to produce beneficial physiological responses.

Latest Patents

Holinski's latest patents include "Systems and methods for neuromodulation of a carotid sinus nerve" and "Neuromodulation device and method for treating metabolic disorders." Both inventions refer to a device designed to inhibit the neural activity of the carotid sinus nerve (CSN) or carotid body. The device comprises one or more transducers that apply a signal to the CSN, controlled by a controller. The physiological responses aimed for include increased insulin sensitivity, improved glucose tolerance, decreased plasma glucose concentration, reduced subcutaneous fat content, and a reduction in obesity.

Career Highlights

Throughout his career, Holinski has worked with various organizations, including Presidio Medical, Inc. and Faculdade de Ciências Médicas da Universidade Nova de Lisboa. His experience in these companies has contributed to his expertise in developing innovative medical devices.

Collaborations

Some of his notable coworkers include Silvia Margarida Vilares Santos Conde and Daniel John Chew. Their collaboration has likely enhanced the development and implementation of Holinski's inventions.

Conclusion

Brad Holinski's contributions to the field of neuromodulation demonstrate his commitment to advancing medical technology. His innovative patents reflect a deep understanding of the physiological mechanisms involved in metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…